- Home
- PCRX vs ESRT Comparison
PCRX vs ESRT Comparison
Compare PCRX & ESRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- ESRT
- Stock Information
- Founded
- PCRX 2006
- ESRT 2011
- Country
- PCRX United States
- ESRT United States
- Employees
- PCRX N/A
- ESRT N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- ESRT Real Estate Investment Trusts
- Sector
- PCRX Health Care
- ESRT Real Estate
- Exchange
- PCRX Nasdaq
- ESRT Nasdaq
- Market Cap
- PCRX 1.2B
- ESRT 1.2B
- IPO Year
- PCRX 2011
- ESRT 2013
- Fundamental
- Price
- PCRX $26.67
- ESRT $7.63
- Analyst Decision
- PCRX Buy
- ESRT Hold
- Analyst Count
- PCRX 6
- ESRT 2
- Target Price
- PCRX $30.00
- ESRT $10.65
- AVG Volume (30 Days)
- PCRX 766.6K
- ESRT 1.3M
- Earning Date
- PCRX 08-05-2025
- ESRT 10-20-2025
- Dividend Yield
- PCRX N/A
- ESRT 1.83%
- EPS Growth
- PCRX N/A
- ESRT N/A
- EPS
- PCRX N/A
- ESRT 0.24
- Revenue
- PCRX $705,848,000.00
- ESRT $763,746,000.00
- Revenue This Year
- PCRX $7.36
- ESRT $3.02
- Revenue Next Year
- PCRX $10.07
- ESRT $2.94
- P/E Ratio
- PCRX N/A
- ESRT $31.94
- Revenue Growth
- PCRX 2.25
- ESRT 1.14
- 52 Week Low
- PCRX $12.61
- ESRT $6.56
- 52 Week High
- PCRX $27.64
- ESRT $11.62
- Technical
- Relative Strength Index (RSI)
- PCRX 67.86
- ESRT 53.54
- Support Level
- PCRX $25.14
- ESRT $7.45
- Resistance Level
- PCRX $27.04
- ESRT $7.63
- Average True Range (ATR)
- PCRX 0.78
- ESRT 0.16
- MACD
- PCRX 0.18
- ESRT 0.05
- Stochastic Oscillator
- PCRX 88.79
- ESRT 77.45
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About ESRT Empire State Realty Trust Inc.
Empire State Realty Trust operates as a pure-play greater New York and Manhattan-focused REIT, featuring its landmark Empire State Building office and observation deck. The company owns and operates around 8.5 million square feet of office space, about 80% of which is located in Manhattan.